Disruption to the receptor activator of the nuclear factor kappa (RANK)–receptor activator of the nuclear factor kappa B ligand (RANKL)–osteoprotegerin (OPG) axis is the basis for the development of bone metastasis [17,18]. Here, TNFRSF11B is linked to bone metastasis.